BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  OMNIlife science Announces First Clinical Evaluations of Revolutionary OMNIBotics Active Spacer Robotic Tissue Balancing Device for Robotic-Assisted Total Knee Replacement

  OMNIlife science announced today that they have begun clinical evaluations of their exclusive OMNIBotics Active Spacer robotic tissue balancing device at three U.S. sites.

  October 31, 2017

   · 

  4 min read
• Genetown

  NeuroMetrix Closes $3.5 Million Equity Offering

  The Company’s common stock closed on October 30, 2017 at $1.80 per share. Proceeds of the offering will be used for commercialization of Quell, the Company’s over-the-counter wearable device for relief of chronic pain and for general working capital purposes.

  October 31, 2017

   · 

  3 min read
• Business

  Zymo Research and VWR Team Up in Strategic Supplier Partnership

  The management at Zymo Research announced today a joint agreement with VWR to sell and distribute Zymo Research’s DNA purification, RNA extraction, microbiomic analysis, and epigenetics products throughout North America.

  October 31, 2017

   · 

  2 min read
• Improved NSAID Gels With 3x Faster Penetration Rates and 48 Hour Sustained Release Developed by Nemaura Pharma

  Sufferers of acute arthritic-related pain using ‘over the counter’ gels to alleviate muscle ache and joint inflammation may be interested in the results of laboratory trials recently carried out by Nemaura Pharma.

  October 31, 2017

   · 

  3 min read
• ANGLE plc: Result of AGM Location

  ANGLE plc, a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.

  October 31, 2017

   · 

  3 min read
• Genetown

  VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares

  VBI also closed its concurrent registered direct offering of 7,475,410 common shares at a price of US$3.05 per share.

  October 31, 2017

   · 

  5 min read
• Business

  Vedantra Pharmaceuticals Extends Research Collaboration With Neon Therapeutics to Develop Novel Cancer Immunotherapies

  Under the extended agreement, Vedantra and Neon will continue to build on research exploring the potential benefits of combining Vedantra’s cutting-edge, lymph node targeting amphiphile technology with Neon’s innovative capabilities in neoantigen vaccine research.

  October 31, 2017

   · 

  3 min read
• Business

  Avinger to Announce Third Quarter 2017 Results on November 9, 2017

  The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

  October 31, 2017

   · 

  1 min read
• Business

  Zogenix to Release Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7

  The company will host a corporate update conference call and webcast on Tuesday, November 7, 2017 at 4:30 PM ET.

  October 31, 2017

   · 

  1 min read
• Business

  Selecta Biosciences to Report Third Quarter 2017 Financial Results and Updated Phase 2 Data for SEL-212 on Tuesday, November 7, 2017

  t 8:30 a.m. ET that day, Selecta will host a conference call to discuss these results and provide a corporate update.

  October 31, 2017

   · 

  3 min read